From: Association between occupational exposure and the clinical characteristics of COPD
All n = 591 | VDGF + N = 209 | VDGF – 382 | P value | |
---|---|---|---|---|
Chronic bronchitis (%) | 73.3 | 75.3 | 72.2 | NS (a) |
Shortness of breath (MRC) | 2 [1–2] | 2 [1–2] | 2 [1–2] | NS (b) |
Life-time wheeze (%) | 65 | 71.9 | 61.1 | 0.0371 (a) |
Exacerbations/patient/yr | 1 [0–3] | 1 [0–3] | 1 [0–3] | NS (b) |
FEV1 (postBD, % predicted) | 49 [35–66] | 51.6 [37.2–67.1] | 47.2 [33.7–65.3] | 0.08 (b) |
GOLD stages (%) | 0.15 (a) | |||
I | 5.6 | 7.7 | 4.5 | |
II | 43 | 44.5 | 42.2 | |
III | 33.2 | 33.5 | 33 | |
IV | 18.3 | 14.4 | 20.4 | |
Current sputum1 | 2 [1–4] | 3 [1 – 4]. | 2 [1 – 4]. | 0.035 (b) |
Current wheeze1* | 1 [0–2] | 2 [0 – 3]. | 1 [0 – 2]. | 0.002 (b) |
Work related respiratory disability * | 1 [0–1] | 1 [0 – 2]. | 0 [0 – 1]. | 0.001 (b) |
SGRQ total score * | 43.7 [30.3-60.0] | 46.2 [32.5-63.4] | 42.0 [29.9-58.2] | NS (b) |